Conjunctivitis, commonly known as pink eye, is an inflammation of the conjunctiva, the thin and transparent membrane covering the white part of the eye and the inner surface of the eyelids. This condition can be caused by viruses, bacteria, allergens, or irritants, leading to redness, itching, tearing, and discharge from the eyes. Viral conjunctivitis is often associated with respiratory infections, while bacterial conjunctivitis can result from various bacteria strains. Allergic conjunctivitis is triggered by allergens like pollen or pet dander, and irritant conjunctivitis can occur due to exposure to smoke or chemicals. Diagnosis involves a thorough eye examination, and treatment depends on the underlying cause. Viral conjunctivitis is typically self-limiting, while bacterial conjunctivitis may require antibiotic eye drops or ointments. Allergic conjunctivitis may be managed with antihistamines or other allergy medications. Preventive measures include practicing good hand hygiene, avoiding touching the eyes, and managing allergies. Conjunctivitis is highly contagious, and individuals with symptoms should take precautions to prevent its spread. Timely diagnosis and appropriate management help alleviate symptoms and reduce the risk of complications.
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Khursheed Anwer
IMUNON, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, ItalySubmit your abstract Today
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States